To investigate whether nasopharyngeal levels of ACE2 and TMPRSS2 are associated with respiratory distress susceptibility on COVID-19 patients, 213 SARS-CoV-2 RT-qPCR positive individuals were enrolled in this case–control study. The gene discussed is ACE2; the disease is COVID-19.